AINNOVATION (02121) expects to announce a profit reminder, predicting an adjusted net profit of 2-4 million yuan for the mid-term, turning losses into profits compared to the same period last year.
Innovative Intelligence (02121) announced that due to increased market demand and improvements in the company's platform capabilities and product standardization, operational efficiency is optimized. The Group expects to record an adjusted net profit (not in accordance with International Financial Reporting Standards) of RMB 2-4 million for the six-month period ending June 30, 2026, a significant improvement compared to the adjusted net loss of RMB 6.681 million recorded in the same period of 2025. The company will adhere to a strategy of sustained pragmatism and long-term development, actively respond to market challenges, strive to help customers reduce costs and increase efficiency, and continuously enhance its technical products and business sustainability.
AINNOVATION (02121) announced that, due to increased market demand and the optimization of operational efficiency brought about by the enhancement of the company's platform capabilities and product standardization, the Group expects to record an adjusted net profit (measured in accordance with non-IFRS) of RMB 2-4 million for the six-month period ending June 30, 2026, a substantial improvement compared to the adjusted net loss of RMB 6.681 million recorded in the same period in 2025. The company will adhere to a strategy of continuous pragmatism and long-term development, actively responding to market challenges, striving to reduce costs and improve efficiency for its clients, while also enhancing its technological products and sustainable business operations.
The company defines the adjusted profit/(loss) as the net loss for the period adjusted by adding back share-based payment expenses, amortization of intangible assets generated from acquisitions, and fair value changes of financial assets/liabilities measured at fair value through profit or loss. The fair value changes of financial assets/liabilities measured at fair value through profit or loss mainly include fair value changes of contingent considerations and other financial investments. The company believes that this non-IFRS measurement tool is beneficial for comparing operational performance across different periods and companies by eliminating the potential impacts of certain items.
Related Articles

In the first seven months, SEAZEN (01030) accumulated contract sales amounting to approximately 7.218 billion yuan, a year-on-year decrease of 39.8%.

JACOBSON PHARMA (02633): Huang Ziheng appointed as independent non-executive director

On August 10, YUM CHINA (09987) invested HK$8.4341 million to repurchase 22,400 shares.
In the first seven months, SEAZEN (01030) accumulated contract sales amounting to approximately 7.218 billion yuan, a year-on-year decrease of 39.8%.

JACOBSON PHARMA (02633): Huang Ziheng appointed as independent non-executive director

On August 10, YUM CHINA (09987) invested HK$8.4341 million to repurchase 22,400 shares.

RECOMMEND





